Lonza Group Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

17:38 EDT 2 Aug 2018 | BioPortfolio Reports

Lonza Group Ltd Strategy, SWOT and Corporate Finance Report


Lonza Group Ltd Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Lonza Group Ltd Lonza or 'the group' is one of the world's leading global suppliers to the pharmaceutical, biotechnology and specialty ingredients markets. The group's products and services range from active pharmaceutical ingredients APIs to drinking water sanitizers, from nutritional and personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that fight dangerous viruses, bacteria and other pathogens. Lonza classifies its business operations into two reportable segments: Specialty Ingredients and Pharma and Biotech. The group operates in Europe, North America, Latin America, Asia, South Africa and other regions of the world. It is headquartered in Basel, Switzerland.


Detailed information on Lonza Group Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Lonza Group Ltd in the form of a SWOT analysis

An indepth view of the business model of Lonza Group Ltd including a breakdown and examination of key business segments

Intelligence on Lonza Group Ltd's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Lonza Group Ltd, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Lonza Group Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Lonza Group Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Lonza Group Ltd's business structure, strategy and prospects.

Original Article: Lonza Group Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175


More From BioPortfolio on "Lonza Group Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175"

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.